The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis
Abstract
Objective: To develop a clinical model for the prediction, at the first visit, of 3 forms of arthritis outcome: self‐limiting, persistent nonerosive, and persistent erosive arthritis. Methods: A standardized diagnostic evaluation was performed on 524 consecutive, newly referred patients with early arthritis. Potentially diagnostic determinants obtained at the first visit from the patient's history, physical examination, and blood and imaging testing were entered in a logistic regression analysis. Arthritis outcome was recorded at 2 years' followup. The discriminative ability of the model was expressed as a receiver operating characteristic (ROC) area under the curve (AUC). Results: The developed prediction model consisted of 7 variables: symptom duration at first visit, morning stiffness for ≥1 hour, arthritis in ≥3 joints, bilateral compression pain in the metatarsophalangeal joints, rheumatoid factor positivity, anti–cyclic citrullinated peptide antibody positivity, and the presence of erosions (hands/feet). Application of the model to an individual patient resulted in 3 clinically relevant predictive values: one for self‐limiting arthritis, one for persistent nonerosive arthritis, and one for persistent erosive arthritis. The ROC AUC of the model was 0.84 (SE 0.02) for discrimination between self‐limiting and persistent arthritis, and 0.91 (SE 0.02) for discrimination between persistent nonerosive and persistent erosive arthritis, whereas the discriminative ability of the American College of Rheumatology 1987 classification criteria for rheumatoid arthritis was significantly lower, with ROC AUC values of 0.78 (SE 0.02) and 0.79 (SE 0.03), respectively. Conclusion: A clinical prediction model was developed with an excellent ability to discriminate, at the first visit, between 3 forms of arthritis outcome. Validation in other early arthritis clinics is necessary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Problems of Spectrum and Bias in Evaluating the Efficacy of Diagnostic Tests
Ransohoff, D. F., & Feinstein, A. R. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810262991705 · Cited by 1,734
Schellekens, G. A., Visser, H., De Jong, B. A. W., Van Den Hoogen, F. H. J., Hazes, J. M. W., Breedveld, F. C., & Van Venrooij, W. J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<155::aid-anr20>3.0.co;2-3 · Cited by 1,450
Self-citationThe Threshold Approach to Clinical Decision Making
Pauker, S. G., & Kassirer, J. P. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005153022003 · Cited by 1,358
(1968) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a067150 · Cited by 1,349
Van Der Heijde, D., Van Riel, P., Gribnau, F., Nuver-Zwart, I., & Van De Putte, L. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92442-2 · Cited by 556
Therapeutic decision making: a cost-benefit analysis
Pauker, S. G., & Kassirer, J. P. (1975) · New England Journal of Medicine · doi:10.1056/nejm197507312930505 · Cited by 507
Factors predicting response to treatment in rheumatoid arthritis: The importance of disease duration
Anderson, J. J., Wells, G., Verhoeven, A. C., & Felson, D. T. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<22::aid-anr4>3.0.co;2-9 · Cited by 503
Cited by
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
Rantapää‐Dahlqvist, S., de Jong, B. A. W., Berglin, E., Hallmans, G., Wadell, G., Stenlund, H., Sundin, U., & van Venrooij, W. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11223 · Cited by 1,953
PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease
Vossenaar, E. R., Zendman, A. J. W., van Venrooij, W. J., & Pruijn, G. J. M. (2003) · BioEssays · doi:10.1002/bies.10357 · Cited by 983
Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment
Schett, G., & Gravallese, E. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.153 · Cited by 947
Nell, V. P. K. (2004) · Rheumatology · doi:10.1093/rheumatology/keh199 · Cited by 818
Combe, B., Landewe, R., Lukas, C., Bolosiu, H. D., Breedveld, F., Dougados, M., Emery, P., Ferraccioli, G., Hazes, J. M. W., Klareskog, L., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.044354 · Cited by 786
Self-citationvan Gaalen, F. A., Linn‐Rasker, S. P., van Venrooij, W. J., de Jong, B. A., Breedveld, F. C., Verweij, C. L., Toes, R. E. M., & Huizinga, T. W. J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20044 · Cited by 639
Self-citationRaza, K., Falciani, F., Curnow, S. J., Ross, E. J., Lee, C.-Y., Akbar, A. N., Lord, J. M., Gordon, C., Buckley, C. D., & Salmon, M. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1733 · Cited by 515
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
Vossenaar, E. R., Després, N., Lapointe, E., van der Heijden, A., Lora, M., Senshu, T., van Venrooij, W. J., & Ménard, H. A. (2004) · Arthritis Res Ther · doi:10.1186/ar1149 · Cited by 463
Vossenaar, E. R., Radstake, T. R. D., van der Heijden, A., van Mansum, M. A. M., Dieteren, C., de Rooij, D.-J., Barrera, P., Zendman, A. J. W., & van Venrooij, W. J. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.012211 · Cited by 455
Forslind, K., Ahlmén, M., Eberhardt, K., Hafström, I., & Svensson, B. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.014233 · Cited by 445
Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
Chen, Y.-F., Jobanputra, P., Barton, P., Jowett, S., Bryan, S., Clark, W., Fry-Smith, A., & Burls, A. (2006) · Health Technology Assessment · doi:10.3310/hta10420 · Cited by 406
Van Gaalen, F. A., Van Aken, J., Huizinga, T. W. J., Schreuder, G. M. T., Breedveld, F. C., Zanelli, E., Van Venrooij, W. J., Verweij, C. L., Toes, R. E. M., & De Vries, R. R. P. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20316 · Cited by 393
Self-citationPrognostic laboratory markers of joint damage in rheumatoid arthritis
Lindqvist, E., Eberhardt, K., Bendtzen, K., Heinegård, D., & Saxne, T. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.019992 · Cited by 367
Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome
Symmons, D. P. M. (2002) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2002.0257 · Cited by 319
Clinical utility of the anti-CCP assay in patients with rheumatic diseases
Lee, D. M., & Schur, P. H. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.9.870 · Cited by 295
Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease
Bouguen, G., Levesque, B. G., Feagan, B. G., Kavanaugh, A., Peyrin–Biroulet, L., Colombel, J., Hanauer, S. B., & Sandborn, W. J. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.09.006 · Cited by 294
Luqmani, R., Hennell, S., Estrach, C., Basher, D., Birrell, F., Bosworth, A., Burke, F., Callaghan, C., Candal-Couto, J., Fokke, C., et al. (2009) · Rheumatology · doi:10.1093/rheumatology/ken450a · Cited by 293
Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis
Wang, S., & Wang, Y. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.07.003 · Cited by 285
Berglin, E., Johansson, T., Sundin, U., Jidell, E., Wadell, G., Hallmans, G., & Rantapää-Dahlqvist, S. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.041376 · Cited by 269
Anti–citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis
Aggarwal, R., Liao, K., Nair, R., Ringold, S., & Costenbander, K. H. (2009) · Arthritis Care & Research · doi:10.1002/art.24827 · Cited by 253
Lubberts, E. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0189-9 · Cited by 173
Baron, M., Schieir, O., Hudson, M., Steele, R., Kolahi, S., Berkson, L., Couture, F., Fitzcharles, M. A., Gagné, M., Garfield, B., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.23314 · Cited by 77
European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders
Wiik, A., Cervera, R., Haass, M., Khamashta, M., Meroni, P., Piette, J.-C., Schmitt, R., & Shoenfeld, Y. (2006) · Lupus · doi:10.1191/0961203306lu2322oa · Cited by 44
Infantino, M., Manfredi, M., Merone, M., Grossi, V., Benucci, M., Li Gobbi, F., Bandinelli, F., Damiani, A., & Soda, P. (2018) · Immunologic Research · doi:10.1007/s12026-018-8992-9 · Cited by 16
“The study included 246 samples from patients suffering from SLE (n = 70) as well as a control group (n = 176), including 96 patients with IA [31], 40 patients with autoimmune thyroiditis, and 40 samples from apparently healthy blood donors.”
Background
Metadata
- Authors
- Visser, H., le Cessie, S., Vos, K., Breedveld, F. C., & Hazes, J. M. W.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2002-02
- Volume
- 46
- Issue
- 2
- Pages
- 357-365
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2043343045
- Cited by
- 731
- References
- 27
- FWCI
- 29.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.